105
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5413-5423 | Received 06 Aug 2022, Accepted 10 Sep 2022, Published online: 18 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)